TY - JOUR
T1 - The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor
AU - Espinosa-Larrañaga, Francisco
AU - Vejar-Jalaf, Margarita
AU - Medina-Santillán, Roberto
PY - 2005/10
Y1 - 2005/10
N2 - In order to discuss and establish a joint position on the treatment of low serum levels of high-density lipoprotein cholesterol (HDL-C), a group of experts involved in the care of people with dyslipidaemia and at risk of cardiovascular disease met in Miami, Florida, US, on 5th and 6th March 2005. The experts came from the Latin American countries Argentina, Brazil, Chile, Colombia, Ecuador, Guatemala, Mexico and Venezuela and had at least five years of experience in the care of patients with dyslipidaemia and low HDL-C. The main objective of the meeting was to discuss and propose a treatment for low serum HDL-C levels as a cardiovascular risk factor in patients and to create a group of useful recommendations in this regard, applicable to the daily clinical practice of physicians dealing with patients with dyslipidaemia and cardiovascular disease. This document describes the methodology developed to obtain these recommendations and presents the results of this academic meeting.
AB - In order to discuss and establish a joint position on the treatment of low serum levels of high-density lipoprotein cholesterol (HDL-C), a group of experts involved in the care of people with dyslipidaemia and at risk of cardiovascular disease met in Miami, Florida, US, on 5th and 6th March 2005. The experts came from the Latin American countries Argentina, Brazil, Chile, Colombia, Ecuador, Guatemala, Mexico and Venezuela and had at least five years of experience in the care of patients with dyslipidaemia and low HDL-C. The main objective of the meeting was to discuss and propose a treatment for low serum HDL-C levels as a cardiovascular risk factor in patients and to create a group of useful recommendations in this regard, applicable to the daily clinical practice of physicians dealing with patients with dyslipidaemia and cardiovascular disease. This document describes the methodology developed to obtain these recommendations and presents the results of this academic meeting.
UR - http://www.scopus.com/inward/record.url?scp=28244497079&partnerID=8YFLogxK
U2 - 10.3132/dvdr.2005.016
DO - 10.3132/dvdr.2005.016
M3 - Artículo
C2 - 16342610
AN - SCOPUS:28244497079
SN - 1479-1641
VL - 2
SP - S1-S8
JO - Diabetes and Vascular Disease Research
JF - Diabetes and Vascular Disease Research
IS - SUPPL. 1
ER -